BRPI0417097A - inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade - Google Patents

inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade

Info

Publication number
BRPI0417097A
BRPI0417097A BRPI0417097-0A BRPI0417097A BRPI0417097A BR PI0417097 A BRPI0417097 A BR PI0417097A BR PI0417097 A BRPI0417097 A BR PI0417097A BR PI0417097 A BRPI0417097 A BR PI0417097A
Authority
BR
Brazil
Prior art keywords
dry powder
dose
dry
powder inhaler
moisture sensitive
Prior art date
Application number
BRPI0417097-0A
Other languages
English (en)
Inventor
Myrman Mattias
Calender Sven
Niemi Alf
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34657779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0417097(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0303269A external-priority patent/SE0303269L/sv
Priority claimed from SE0303569A external-priority patent/SE0303569L/sv
Application filed by Microdrug Ag filed Critical Microdrug Ag
Publication of BRPI0417097A publication Critical patent/BRPI0417097A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"INALADOR DE Pó SECO DE DOSE PREVIAMENTE MEDIDA PARA MEDICAMENTOS SENSìVEIS à UMIDADE". A presente invenção é dirigida para um inalador de pó seco previamente medido, provido com uma dose de pó seco de tiotrópio e excipiente(s), introduzida dentro de um recipiente que compreende um lacre seco, de característica de alto grau de barreira, que evita a entrada de umidade, de modo que a estrutura de partículas finas da dose de pó é preservada. A dose de pó seco foi produzida através de métodos de produção volumétrica de dose ou de produção de dose por meio de campo elétrico. A invenção é também dirigida a uma dose de pó seco de tiotrópio introduzida em um recipiente conforme descrito acima. O inalador de pó seco e a dose de pó seco, de acordo com a invenção, são idealizados para uso no tratamento de asma e outros distúrbios respiratórios.
BRPI0417097-0A 2003-12-03 2004-12-02 inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade BRPI0417097A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0303269A SE0303269L (sv) 2003-12-03 2003-12-03 Medicinsk produkt
SE0303569A SE0303569L (sv) 2003-12-03 2003-12-22 DPI för avlämning av fuktkänsliga medikament
US10/933,219 US20050121032A1 (en) 2003-12-03 2004-09-03 Pre-metered dry powder inhaler for moisture-sensitive medicaments
PCT/SE2004/001794 WO2005053648A1 (en) 2003-12-03 2004-12-02 Pre-metered dry powder inhaler for moisture-sensitive medicaments

Publications (1)

Publication Number Publication Date
BRPI0417097A true BRPI0417097A (pt) 2007-03-13

Family

ID=34657779

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417097-0A BRPI0417097A (pt) 2003-12-03 2004-12-02 inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade

Country Status (8)

Country Link
EP (1) EP1691783B1 (pt)
JP (1) JP2007512898A (pt)
KR (1) KR101315690B1 (pt)
AU (1) AU2004294890B2 (pt)
BR (1) BRPI0417097A (pt)
CA (1) CA2547245A1 (pt)
PL (1) PL1691783T3 (pt)
WO (1) WO2005053648A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7080644B2 (en) 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
KR101131691B1 (ko) 2004-02-24 2012-03-28 마이크로도스 테라퓨특스, 인코포레이티드 방향성 흐름 센서 흡입기
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
LT3578169T (lt) 2009-02-26 2024-08-26 Glaxo Group Limited Farmaciniai preparatai, apimantys 4-{(1r)-2-[(6-{2-[(2,6-dichlorbenzil) oksi]etoksi}heksil)amino]-1-hidroksietil}-2-(hidroksimetil)fenolį
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
NZ596564A (en) 2009-05-21 2012-11-30 Microdose Therapeutx Inx Rotary cassette system for dry powder inhaler with blister packs, a vibrating element and a piercing element
TR200907913A2 (tr) * 2009-10-20 2011-05-23 Bi̇lgi̇ç Mahmut İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
TR200907915A2 (tr) * 2009-10-20 2011-05-23 Bi̇lgi̇ç Mahmut Kuru toz formunda farmasötik bileşim.
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
TR201000681A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut İnhalasyon yoluyla alınan kuru toz formülasyonları.
WO2011093813A1 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic Dry powder pharmaceutical composition comprising tiotropium and fluticasone
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
TR201000680A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
TR201000679A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Farmasötik bir kombinasyon içeren kuru toz formülasyonları.
WO2011093812A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
TR201000733A2 (tr) * 2010-02-02 2011-08-22 Bi̇lgi̇ç Mahmut Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
EA201790833A1 (ru) * 2014-10-16 2017-09-29 Тева Брэндид Фармасьютикал Продактс Ар Энд Ди, Инк. Сухой порошкоообразный состав
WO2018071427A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
ATE312638T1 (de) * 1998-06-12 2005-12-15 Microdose Technologies Inc Vorrichtung zur abgabe von arzneimitteln
US6146685A (en) * 1998-11-05 2000-11-14 Delsys Pharmaceutical Corporation Method of deposition a dry powder and dispensing device
JP4540906B2 (ja) * 1999-06-05 2010-09-08 イノバータ・バイオメッド・リミテッド 放出システム
YU26802A (sh) * 1999-10-11 2004-11-25 Ml Laboratories Plc. Uređaj za raspršivanje leka sa oblogom otpornom na vlagu
PE20020066A1 (es) * 2000-06-23 2002-02-23 Norton Healthcare Ltd Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
SK285389B6 (sk) * 2000-10-12 2006-12-07 Boehringer Ingelheim Pharma Kg Inhalačný prášok s obsahom tiotrópia, kapsula s jeho obsahom a ich použitie
WO2003000326A1 (en) * 2001-06-20 2003-01-03 Nektar Therapeutics Powder aerosolization apparatus and method
SE522558C2 (sv) * 2001-07-13 2004-02-17 Microdrug Ag Förfarande och anordning för styrning av överföring av elektriskt laddade partiklar av ett medicinskt pulver till en målarea på ett substratelement vid en dosutformningsprocess
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
DE10202940A1 (de) * 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
GB0202912D0 (en) * 2002-02-07 2002-03-27 Meridica Ltd Method and apparatus for introducing powder into a pocket
AU2003225973A1 (en) * 2002-03-26 2003-11-11 Glaxo Group Limited A method for forming a laminate assembly and products formed thereby
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
EP1905205B1 (en) * 2005-07-04 2014-05-07 SK Telecom Co., Ltd. Residential gateway system for home network service

Also Published As

Publication number Publication date
AU2004294890A1 (en) 2005-06-16
WO2005053648A1 (en) 2005-06-16
EP1691783A1 (en) 2006-08-23
PL1691783T3 (pl) 2010-05-31
CA2547245A1 (en) 2005-06-16
EP1691783B1 (en) 2009-11-25
KR101315690B1 (ko) 2013-10-22
AU2004294890B2 (en) 2010-08-26
JP2007512898A (ja) 2007-05-24
KR20070007257A (ko) 2007-01-15
WO2005053648A8 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
BRPI0417097A (pt) inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade
Nan et al. The function of natural compounds in important anticancer mechanisms
BR0009975A (pt) Inalador de pó para um medicamento combinado
SE0303570D0 (sv) Moisture-sensitive medical product
BR0009976A (pt) Inalador de pó para um medicamento combinado
BRPI0409623A (pt) produto farmacêutico, método de preparação do mesmo e uso de substáncias na preparação do referido produto farmacêutico
CY1110636T1 (el) Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
BRPI0417155A (pt) produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade
BR0316264A (pt) Medicamento para tratamento de doença pulmonar obstrutiva crÈnica
BR0012351A (pt) Pós consistindo de partìculas com uma superfìcie perfeitamente macia, para uso como veìculos para a preparação de misturas de inalação com medicamentos micronizados e o método para sua preparação
BR112013015207A2 (pt) Sistema de anestesia extensível, integrado
WO2008154083A3 (en) Compounds, compositions and methods for the treatment of synucleinopathies
IL204052A (en) Annotation of 1,1,1 - Tripluoro - 2 - Hydroxy - 3 - Phenylpropane
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
BRPI0607168A2 (pt) terapia de combinação parenteral, composição farmacêutica, processo para preparar uma composição farmacêutica e método de tratamento
BR112015024621A8 (pt) usos de dose unitária de unidades formadoras de colônia de c. novyi, composição farmacêutica compreendendo a referida dose unitária, kit para tratar ou atenuar um efeito de um tumor sólido presente em um ser humano e dose unitária de unidades formadoras de colônia de c. novyi
BRPI0408744A (pt) 4-feniltetrahidroisoquinolinas substituìdas, processos para preparação das mesmas, seu uso como medicamento, bem como medicamento que contém as mesmas
BR112012016570A2 (pt) composto, composição farmacêutica, método para antagonizar a heparina não fracionada, heparina de peso molecular baixo, ou derivado de heparina /heparina de peso molecular baixo, e, uso do composto
ATE447939T1 (de) Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren
BRPI0313647A2 (pt) composições de inalação
MX373699B (es) Composicion farmaceutica que contiene budesonida y formoterol.
EA200500387A1 (ru) Композиции для ингаляции с высоким содержанием лекарственных веществ
BR112022025401A2 (pt) Componente para um sistema de distribuição e sistema de distribuição
BRPI0607258A2 (pt) uso, composto, bem como formulações farmacêuticas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE)

Free format text: TRANSFERIDO DE: MICRODRUG AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL